Lexaria Bioscience's total assets for Q1 2026 were $6.05M, an increase of 44.93% from the previous quarter. LEXX total liabilities were $1.53M for the fiscal quarter, a -2.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.